SCHEMBL8086764

SCHEMBL8086764

C=C(Nc1cccc(OC)c1)c1ccc(NCC)c(C(F)(F)F)c1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.45
NPC1 O15118 3/20 0.45
ALDH1A1 P00352 2/20 0.43
TP53 P04637 1/20 0.43
PKM P14618 1/20 0.43
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
PDK1 Q15118 1/20 0.42
PDK2 Q15119 1/20 0.42
PDK3 Q15120 1/20 0.42
PDK4 Q16654 1/20 0.42
LMNA P02545 1/20 0.42
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42
EPHX2 P34913 2/20 0.41
RXFP1 Q9HBX9 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
HPGD P15428 1/20 0.40
NLRP3 Q96P20 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8086282 0.92 MAPT (0.44) RAB9ANPC1ALDH1A1TP53PKM
SCHEMBL4247305 0.87 RAB9A (0.58) RAB9ANPC1ALDH1A1TP53PKM
SCHEMBL8086791 0.80 NPC1 (0.51) RAB9ANPC1ALDH1A1TP53PKM
SCHEMBL4250840 0.79 RAB9A (0.56) RAB9ANPC1ALDH1A1TP53PKM
SCHEMBL4249452 0.78 MAPT (0.56) RAB9ANPC1ALDH1A1TP53PKM
SCHEMBL4254188 0.77 RAB9A (0.56) RAB9ANPC1ALDH1A1TP53PKM
SCHEMBL8086177 0.75 RAF1 (0.53) NPC1ALDH1A1TAAR1
SCHEMBL4251690 0.75 RAB9A (0.56) RAB9ANPC1ALDH1A1TP53PKM
SCHEMBL4247072 0.74 RXFP1 (0.62) RAB9ANPC1ALDH1A1TP53PKM
SCHEMBL8091906 0.72 NPC1 (0.56) RAB9ANPC1ALDH1A1TP53PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009016088-A1 THE USE OF BENZAMIDE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2009-02-05 WO disclosed